W Mehnert

Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.

B. Röder, K. Danker, H. Korting, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization.

W Mehnert, C Schwarz, W. Mehnert, 1999, Journal of microencapsulation.

Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.

W Mehnert, C Schwarz, W. Mehnert, 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.

A F Thünemann, R. Müller, A. Thünemann, 2006, International journal of pharmaceutics.

Solid lipid nanoparticles: production, characterization and applications.

K. Mäder, W Mehnert, K Mäder, 2001, Advanced drug delivery reviews.

Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.

R. Müller, R H Müller, W Mehnert, 1996, Journal of drug targeting.